Neoadjuvant Pertuzumab Biosimilar HLX11 versus Reference Pertuzumab for Early-Stage or Locally Advanced Breast Cancer: A Phase III Equivalence Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Cancer Research
Authors: Jin Zhang, Jinhai Zhu, Yaping Yang, Dong Song, Tao Huang, Xiaopeng Ma, Qinguo Mo, Xiaobo Du, Chunwei Xie, Yu Ren, Fan Li, Bo Zhang, Xujuan Wang, Zhaofeng Niu, Hongsheng Li, Peifen Fu, Qingyuan Zhang, Minying Li, Xiaoyu Liu, Qitang Wang, Ying Yi, Zhuorong Chen, Yanlan Fan, Futang Yang, Haoyu Yu, Jing Li, Qingyu Wang, Erwei Song, Qiang Liu, the HLX11-BC301 Study Group, Dongyan Cai, Zhenhai Cai, Xia Chen, Yiding Chen, Zhuorong Chen, Fangbo Cui, Guozhong Cui, Xiaobo Du, Zhaoqing Fan, Peifen Fu, Kangsheng Gu, Yuanting Gu, Jianjun Huang, Tao Huang, Yinghua Ji, Guocong Jia, Aimei Jiang, Fan Li, Guolou Li, Hongsheng Li, Jianhui Li, Liang Li, Man Li, Minying Li, Taolang Li, Jinping Liu, Qiang Liu, Xiaoan Liu, Xiaoyu Liu, Jie Ma, Xiaopeng Ma, Xuli Meng, Qinguo Mo, Jianyun Nie, Zhaofeng Niu, Quchang Ouyang, Zhong Ouyang, Guangdong Qiao, Yu Ren, Feng Rong, Dong Song, Erwei Song, Jing Sun, Sanyuan Sun, Tong Tang, Haibo Wang, Hongyan Wang, Qitang Wang, Shoumang Wang, Weibo Wang, Xujuan Wang, Yabing Wang, Zhihong Wang, Limin Wei, Jundong Wu, Xinhong Wu, Zhiyong Wu, Chunwei Xie, Hua Yang, Yaping Yang, Yongzhong Yao, Yumin Yao, Wenjun Yi, Ying Yi, Wei You, Guohua Yu, Bo Zhang, Hao Zhang, Jin Zhang, Lili Zhang, Qiang Zhang, Qingyuan Zhang, Yuanqi Zhang, Ke Zheng, Yong Zhou, Jinhai Zhu
Institutions: Tianjin Medical University Cancer Institute and Hospital, Bengbu Medical College, First Affiliated Hospital of Bengbu Medical College, Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Jilin University, First Hospital of Jilin University, Wuhan Union Hospital, Union Hospital, Anhui Provincial Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Mianyang Central Hospital, Third Hospital of Nanchang, Second Hospital of Nanchang, First Affiliated Hospital of Xi'an Jiaotong University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University, Shanxi Provincial Cancer Hospital, Neijiang Normal University, Yuncheng University, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University, First Affiliated Hospital Zhejiang University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Zhongshan People's Hospital, Chongqing Cancer Hospital, Qingdao University, Affiliated Hospital of Qingdao University, Qingdao Municipal Hospital, Viva Biotech (China), Deyang Stomatological Hospital, Shantou University, Yue Bei People's Hospital
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G163480135
OpenAlex ID: W7212027247
FWCI:
Cites:
Cited by:
Related to: